"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.
The populist government under President Andrés Manuel López Obrador has largely discounted the threat of COVID-19, and the true extent of the outbreak Mexico may not yet be known. If conditions significantly change for the worse, the president faces not only a public health crisis but also the possible undoing of the country's populist experiment.
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
The United States' exit from the Intermediate-range Nuclear Forces Treaty appears more like a gesture than part of a well-considered long-term plan. There are few signs that the Trump administration has given substantial thought to how the U.S. can best protect its interests in a new and challenging international environment.
The good news: we managed to get through June and July without war in the Persian Gulf. The bad news: the risk of conflict remains high. Read more at the Baker Institute Blog: https://bit.ly/2MKqWDS
The massacre in El Paso is a symbol of complex social phenomena that we are experiencing today — and is not simply a matter of mental health, as Texas Gov. Greg Abbott and other politicians have stepped forward to suggest. Read more at the Baker Institute Blog.
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.